These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8896488

  • 1. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2.
    Carmack MA, Yasukawa LL, Chang SY, Tran C, Saldana F, Arvin AM, Prober CG.
    J Infect Dis; 1996 Nov; 174(5):899-906. PubMed ID: 8896488
    [Abstract] [Full Text] [Related]

  • 2. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
    Torseth JW, Cohen GH, Eisenberg RJ, Berman PW, Lasky LA, Cerini CP, Heilman CJ, Kerwar S, Merigan TC.
    J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
    [Abstract] [Full Text] [Related]

  • 3. Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex.
    Westra DF, Verjans GMGM, Osterhaus ADME, van Kooij A, Welling GW, Scheffer AJ, The TH, Welling-Wester S.
    J Gen Virol; 2000 Aug; 81(Pt 8):2011-2015. PubMed ID: 10900040
    [Abstract] [Full Text] [Related]

  • 4. Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccine.
    Ashley RL, Crisostomo FM, Doss M, Sekulovich RE, Burke RL, Shaughnessy M, Corey L, Polissar NL, Langenberg AG.
    J Infect Dis; 1998 Jul; 178(1):1-7. PubMed ID: 9652416
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT, Marshall JD, Dorwart MR, Heeke DS, Rao E, Tummala P, Yu L, Cohen GH, Eisenberg RJ, Sloan DD.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28228587
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Moderate exercise is associated with enhanced antigen-specific cytokine, but not IgM antibody production in aged mice.
    Kohut ML, Boehm GW, Moynihan JA.
    Mech Ageing Dev; 2001 Aug 01; 122(11):1135-50. PubMed ID: 11389929
    [Abstract] [Full Text] [Related]

  • 11. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine.
    Kohl S, Charlebois ED, Sigouroudinia M, Goldbeck C, Hartog K, Sekulovich RE, Langenberg AG, Burke RL.
    J Infect Dis; 2000 Jan 01; 181(1):335-9. PubMed ID: 10608784
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection.
    Singh R, Kumar A, Creery WD, Ruben M, Giulivi A, Diaz-Mitoma F.
    Clin Exp Immunol; 2003 Jul 01; 133(1):97-107. PubMed ID: 12823283
    [Abstract] [Full Text] [Related]

  • 17. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L, Bertrand G, McNamara CD, Gras-Masse H, Hammer J, Wechsler SL, Nesburn AB.
    J Virol; 2003 Sep 01; 77(17):9463-73. PubMed ID: 12915561
    [Abstract] [Full Text] [Related]

  • 18. Herpes simplex virus type 1 (HSV-1) specific T-cell generation from HLA-A1- and HLA-A2-positive donors for adoptive immunotherapy.
    Ma CK, Clancy L, Deo S, Blyth E, Micklethwaite KP, Gottlieb DJ.
    Cytotherapy; 2017 Jan 01; 19(1):107-118. PubMed ID: 27793552
    [Abstract] [Full Text] [Related]

  • 19. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.
    Kim M, Osborne NR, Zeng W, Donaghy H, McKinnon K, Jackson DC, Cunningham AL.
    J Immunol; 2012 May 01; 188(9):4158-70. PubMed ID: 22467654
    [Abstract] [Full Text] [Related]

  • 20. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM, Huang ZY, Gallagher JR, Lin Y, Lou H, Whitbeck JC, Wald A, Cohen GH, Eisenberg RJ.
    J Virol; 2015 Sep 01; 89(18):9213-31. PubMed ID: 26109729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.